# Shinva Medical Instrument to acquire 36.19% stake in Wuhan Zhongzhi Biotechnologies for $22.8M

Shinva Medical Instrument Co., Ltd announced it will acquire a 36.1913% stake in Wuhan Zhongzhi Biotechnologies Inc. for RMB166.5 million (USD22.8 million) to expand its in vitro diagnostics (IVD) product pipeline.

- Type: Acquisition
- Announced: 2024-12-31
- Where: China
- Value: $22.8M (166.5M CNY)
- Status: announced
- Products: RNA molecule in vitro diagnostic (IVD) kits, respiratory infection pathogen detection kits, reproductive tract infection pathogen detection kits, intestinal infection pathogen detection kits
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Shinva Medical Instrument](https://endata.com/companies/82070.md) (acquirer)
- [Wuhan Zhongzhi Biotechnologies](https://endata.com/companies/82071.md) (target)

## Sources

- [flcube.com](https://flcube.com/?p=20352), 2024-12-31: "Shinva Medical expects to significantly bolster its IVD product pipeline, thereby enhancing its overall competitiveness in the medical diagnostics market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.